will medicare pay for glp 1 drugs A KFF analysis shows that use of and spending GLP-1 under grew substantially between 2019 and 2024, reflecting their effectiveness in treating type 2 diabetes and other conditions. Medicare Medicare Bridge Program Explained: GLP-1
Description
GLP-1 secretion itself is stimulated in response to food intake ( GLP-1 was discovered in 1981 when it was isolated from the pancreatic islet of anglerfish
doi: 10.3109/00365528009181538
Bloomgarden 2024)
Chiba, T., Kimura, Y., Suzuki, S., Tatefuji, T., & Umegaki, K
The study found that taking Zepbound or another GLP-1 drug had little to no impact on someones risk of breast, kidney, thyroid, and pancreatic cancers. The drug did not appear to affect someones risk for eight other types of obesity-related cancers
Cardiovascular safety trials for all new diabetes mellitus drugs
